Progress in therapy for Duchenne muscular dystrophy. (Q37908904)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21804140%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

review article

1 reference

title

Progress in therapy for Duchenne muscular dystrophy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21804140%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Rebecca J Fairclough

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21804140%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Akshay Bareja

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21804140%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Kay E Davies

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21804140%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

31 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21804140%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

published in

Experimental Physiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21804140%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21804140%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21804140%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

1101-1113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21804140%20AND%20SRC:MED&resulttype=core&format=json

Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations

9 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Absence of alpha-syntrophin leads to structurally aberrant neuromuscular synapses deficient in utrophin

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Utrophin lacks the rod domain actin binding activity of dystrophin

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Calcineurin-NFAT signaling, together with GABP and peroxisome PGC-1{alpha}, drives utrophin gene expression at the neuromuscular junction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Isolation and enrichment of skeletal muscle progenitor cells from mouse bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Therapeutics for Duchenne muscular dystrophy: current approaches and future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

A second promoter provides an alternative target for therapeutic up-regulation of utrophin in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Interventions for muscular dystrophy: molecular medicines entering the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

High dose weekly oral prednisone improves strength in boys with Duchenne muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

The artificial zinc finger coding gene 'Jazz' binds the utrophin promoter and activates transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Molecular mechanisms of muscular dystrophies: old and new players

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Molecular and functional analysis of the utrophin promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

CT-GalNAc transferase overexpression in adult mice is associated with extrasynaptic utrophin in skeletal muscle fibres

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

The urokinase plasminogen activator: an interesting way to improve myoblast migration following their transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Very mild muscular dystrophy associated with the deletion of 46% of dystrophin

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Read-through strategies for suppression of nonsense mutations in Duchenne/ Becker muscular dystrophy: aminoglycosides and ataluren (PTC124).

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Non-toxic ubiquitous over-expression of utrophin in the mdx mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

RhoA leads to up-regulation and relocalization of utrophin in muscle fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Adenovirus-mediated utrophin gene transfer mitigates the dystrophic phenotype of mdx mouse muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient mice by morpholino-oligomer-mediated exon-skipping

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Engineering exon-skipping vectors expressing U7 snRNA constructs for Duchenne muscular dystrophy gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Induction of utrophin gene expression by heregulin in skeletal muscle cells: role of the N-box motif and GA binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Molecular treatments in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Unexpected modes of PDZ domain scaffolding revealed by structure of nNOS-syntrophin complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

ZZ domain is essentially required for the physiological binding of dystrophin and utrophin to beta-dystroglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Identification and characterization of the dystrophin anchoring site on beta-dystroglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

alpha1-syntrophin gene disruption results in the absence of neuronal-type nitric-oxide synthase at the sarcolemma but does not induce muscle degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Myoblast transfer in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Complete genetic correction of ips cells from Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Pharmacological strategies for muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Immunolocalization and developmental expression of dystrophin related protein in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Heregulin ameliorates the dystrophic phenotype in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Adeno-associated virus-mediated microdystrophin expression protects young mdx muscle from contraction-induced injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Sequences of junction fragments in the deletion-prone region of the dystrophin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Dystrophin immunity in Duchenne's muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Pharmacological activation of PPARbeta/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Cell transplantation and gene therapy in muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Morpholinos and their peptide conjugates: therapeutic promise and challenge for Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Invited review: myoblast transfer: a possible therapy for inherited myopathies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

The survival of myoblasts after intramuscular transplantation is improved when fewer cells are injected.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

The role of basal and myogenic factors in the transcriptional activation of utrophin promoter A: implications for therapeutic up-regulation in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Differential membrane localization and intermolecular associations of alpha-dystrobrevin isoforms in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Dystrophin protects the sarcolemma from stresses developed during muscle contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Expression of dog microdystrophin in mouse and dog muscles by gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Dystrophin and dystrophin-related protein (utrophin) distribution in normal and dystrophin-deficient skeletal muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Overactivity of exercise-sensitive cation channels and their impaired modulation by IGF-1 in mdx native muscle fibers: beneficial effect of pentoxifylline

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Identification of spectrin-like repeats required for high affinity utrophin-actin interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

The dystrophin complex forms a mechanically strong link between the sarcolemma and costameric actin

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Dystrobrevin and dystrophin: an interaction through coiled-coil motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Efficacy of myoblast transplantation in nonhuman primates following simple intramuscular cell injections: toward defining strategies applicable to humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Functional substitution by TAT-utrophin in dystrophin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Calpain translocation during muscle fiber necrosis and regeneration in dystrophin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Prevention of pathology in mdx mice by expression of utrophin: analysis using an inducible transgenic expression system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Expression of full-length utrophin prevents muscular dystrophy in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Primary structure of dystrophin-related protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Solution structure of the extended neuronal nitric oxide synthase PDZ domain complexed with an associated peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Expression of dystrophin-associated glycoproteins during human fetal muscle development: a preliminary immunocytochemical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Pharmacological treatments for Duchenne and Becker dystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

A- and B-utrophin have different expression patterns and are differentially up-regulated in mdx muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

PTC124 targets genetic disorders caused by nonsense mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Mammalian animal models for Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Dose-dependent restoration of dystrophin expression in cardiac muscle of dystrophic mice by systemically delivered morpholino

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Identification of alpha-syntrophin binding to syntrophin triplet, dystrophin, and utrophin

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Effective exon skipping and restoration of dystrophin expression by peptide nucleic acid antisense oligonucleotides in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Targeting fibrosis in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Three mouse models of muscular dystrophy: the natural history of strength and fatigue in dystrophin-, dystrophin/utrophin-, and laminin α2-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

The artificial gene Jazz, a transcriptional regulator of utrophin, corrects the dystrophic pathology in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Dystrophin glycoprotein complex dysfunction: A regulatory link between muscular dystrophy and cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2010.053025

10.1113/EXPPHYSIOL.2010.053025

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21804140%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference